Glycans as Biofunctional Ligands for Gold Nanorods: Stability and Targeting in Protein-Rich Media

被引:90
|
作者
Garcia, Isabel [1 ,2 ]
Sanchez-Iglesias, Ana [1 ]
Henriksen-Lacey, Malou [1 ]
Grzelczak, Marek [1 ,3 ]
Penades, Soledad [1 ,2 ]
Liz-Marzan, Luis M. [1 ,2 ,3 ]
机构
[1] CIC biomaGUNE, Paseo Miramon 182, Donostia San Sebastian 20009, Spain
[2] Biomed Res Networking Ctr Bioengn Biomat & Nanome, Aragon 50018, Spain
[3] Basque Fdn Sci, Ikerbasque, Bilbao 48013, Spain
关键词
WHEAT-GERM-AGGLUTININ; BIOMEDICAL APPLICATIONS; DRUG-DELIVERY; NANOPARTICLES; CARBOHYDRATE; GLYCONANOPARTICLES; SURFACE; CORONA; GALECTIN-3; CANCER;
D O I
10.1021/jacs.5b01001
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Poly(ethylene glycol) (PEG) has become the gold standard for stabilization of plasmonic nanoparticles (NPs) in biofluids, because it prevents aggregation while minimizing unspecific interactions with proteins. Application of Au NPs in biological environments requires the use of ligands that can target selected receptors, even in the presence of protein-rich media. We demonstrate here the stabilizing effect of low-molecular-weight glycans on both spherical and rod-like plasmonic NPs under physiological conditions, as bench-marked against the well-established PEG ligands. Glycan-coated NPs are resistant to adsorption of proteins from serum-containing media and avoid phagocytosis by macrophage-like cells, but retain selectivity toward carbohydrate-binding proteins in protein-rich biological media. These results open the way toward the design of efficient therapeutic/diagnostic glycan-decorated plasmonic nanotools for specific biological applications.
引用
收藏
页码:3686 / 3692
页数:7
相关论文
共 28 条
  • [21] Glutathione modified gold nanorods with excellent biocompatibility and weak protein adsorption, targeting imaging and therapy toward tumor cells
    Wang, Jing
    Dong, Biao
    Chen, Boting
    Xu, Sai
    Zhang, Shuang
    Yu, Wei
    Xu, Chunxiang
    Song, Hongwei
    DALTON TRANSACTIONS, 2013, 42 (32) : 11548 - 11558
  • [22] Polyethylene glycol-based bidentate ligands to enhance quantum dot and gold nanoparticle stability in biological media
    Bing C Mei
    Kimihiro Susumu
    Igor L Medintz
    Hedi Mattoussi
    Nature Protocols, 2009, 4 : 412 - 423
  • [23] Polyethylene glycol-based bidentate ligands to enhance quantum dot and gold nanoparticle stability in biological media
    Mei, Bing C.
    Susumu, Kimihiro
    Medintz, Igor L.
    Mattoussi, Hedi
    NATURE PROTOCOLS, 2009, 4 (03) : 412 - 423
  • [24] Targeting heat shock protein 70 using gold nanorods enhances cancer cell apoptosis in low dose plasmonic photothermal therapy
    Ali, Moustafa R. K.
    Ali, Hala R.
    Rankin, Carl R.
    El-Sayed, Mostafa A.
    BIOMATERIALS, 2016, 102 : 1 - 8
  • [25] Anti protein A antibody-gold nanorods conjugate: a targeting agent for selective killing of methicillin resistant Staphylococcus aureus using photothermal therapy method
    Rasoul Shokri
    Mojtaba Salouti
    Rahim Sorouri Zanjani
    Journal of Microbiology, 2015, 53 : 116 - 121
  • [26] Anti protein A antibody-gold nanorods conjugate: a targeting agent for selective killing of methicillin resistant Staphylococcus aureus using photothermal therapy method
    Shokri, Rasoul
    Salouti, Mojtaba
    Zanjani, Rahim Sorouri
    JOURNAL OF MICROBIOLOGY, 2015, 53 (02) : 116 - 121
  • [27] Hemoglobin bioconjugates with surface-protected gold nanoparticles in aqueous media: The stability depends on solution pH and protein properties
    del Cano, Rafael
    Mateus, Lucia
    Sanchez-Obrero, Guadalupe
    Manuel Sevilla, Jose
    Madueno, Rafael
    Blazquez, Manuel
    Pineda, Teresa
    JOURNAL OF COLLOID AND INTERFACE SCIENCE, 2017, 505 : 1165 - 1171
  • [28] Protein-rich foods, sea foods, and gut microbiota amplify immune responses in chronic diseases and cancers - Targeting PERK as a novel therapeutic strategy for chronic inflammatory diseases, neurodegenerative disorders, and cancer
    Saaoud, Fatma
    Lu, Yifan
    Xu, Keman
    Shao, Ying
    Pratico, Domenico
    Vazquez-Padron, Roberto I.
    Wang, Hong
    Yang, Xiaofeng
    PHARMACOLOGY & THERAPEUTICS, 2024, 255